Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma

Status unconfirmed · Phase 3

Conditions studied: Melanoma (Skin)

In brief

RATIONALE: Interferon alfa may interfere with the growth of cancer cells.Vaccines may make the body build an immune response to kill tumor cells. It is not yet known whether melanoma vaccine plus interferon alfa is more effective than interferon alfa alone in treating patients with metastatic melanoma. PURPOSE: Randomized phase III trial to compare the effectiveness of interferon alfa with or without vaccine therapy in treating patients with metastatic melanoma.

Key facts

Study ID

NCT00002767

Run by

GlaxoSmithKline

People needed

300

Starts

1996-01-01

Last updated by the study team

2014-01-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Alabama Comprehensive Cancer Center — Birmingham, Alabama, United States
• Beckman Research Institute, City of Hope — Duarte, California, United States
• University of California San Diego Cancer Center - La Jolla — La Jolla, California, United States
• Kaiser Permanente Medical Center - Oakland — Oakland, California, United States
• Kaiser Permanente Medical Center-Sacramento — Sacramento, California, United States
• UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
• Kaiser Permanente Medical Group - San Francisco — San Francisco, California, United States
• Kaiser Permanente Medical Center - Santa Clara — Santa Clara, California, United States
• Kaiser Permanente Medical Center - Vallejo — Vallejo, California, United States
• University of Connecticut Health Center — Farmington, Connecticut, United States
• Yale Comprehensive Cancer Center — New Haven, Connecticut, United States
• Sylvester Cancer Center, University of Miami — Miami, Florida, United States
• Adventist Health System/Sunbelt, Inc. — Orlando, Florida, United States
• Emory University School of Medicine — Atlanta, Georgia, United States
• Lutheran General Cancer Care Center — Park Ridge, Illinois, United States
• University of Louisville Hospital — Louisville, Kentucky, United States
• Creighton University Cancer Center — Omaha, Nebraska, United States
• Norris Cotton Cancer Center — Lebanon, New Hampshire, United States
• University of New Mexico Cancer Research & Treatment Center — Albuquerque, New Mexico, United States
• Interlakes Oncology/Hematology PC — Rochester, New York, United States
• Duke Comprehensive Cancer Center — Durham, North Carolina, United States
• Barrett Cancer Center, The University Hospital — Cincinnati, Ohio, United States
• Christ Hospital — Cincinnati, Ohio, United States
• CCOP - Columbus — Columbus, Ohio, United States
• Hematology Oncology Consultants Inc — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.